@ PhaseIII
April 19, 2025 at 12:29 AM
@ PhaseIII
7:00 - NTG
7:45 - KHTO
8:30 - kuuma
9:15 - DJ School Pizza
10:00 - banoodle
10:45 - tweak!
11:30 - phaseIII
12:15 - P&K
7:45 - KHTO
8:30 - kuuma
9:15 - DJ School Pizza
10:00 - banoodle
10:45 - tweak!
11:30 - phaseIII
12:15 - P&K
April 19, 2025 at 7:25 PM
7:00 - NTG
7:45 - KHTO
8:30 - kuuma
9:15 - DJ School Pizza
10:00 - banoodle
10:45 - tweak!
11:30 - phaseIII
12:15 - P&K
7:45 - KHTO
8:30 - kuuma
9:15 - DJ School Pizza
10:00 - banoodle
10:45 - tweak!
11:30 - phaseIII
12:15 - P&K
The recordings from MaidStation are starting to go live on YouTube! First one is phaseIII's set from Friday!
Go check it and keep your eyes peeled for the next ones!
youtu.be/GCIiFdW1gFE
Go check it and keep your eyes peeled for the next ones!
youtu.be/GCIiFdW1gFE
[DJ Mix] phaseIII - MaidStation Day 1
YouTube video by RaveStation Records
youtu.be
June 2, 2025 at 11:31 PM
The recordings from MaidStation are starting to go live on YouTube! First one is phaseIII's set from Friday!
Go check it and keep your eyes peeled for the next ones!
youtu.be/GCIiFdW1gFE
Go check it and keep your eyes peeled for the next ones!
youtu.be/GCIiFdW1gFE
Oui, petit report de deux semaines. Les décalages, c'est toujours frustrant, mais celui-ci a néanmoins l'intérêt de nous rapprocher des publis comics et manga de la vague 2 ET de vous permettre de lire ce récit le jour de la Saint Valentin... Ce qui tombe plutôt pas mal 👉👈 #HauteRépublique #PhaseIII
La sortie du roman Pocket Star Wars La Haute République : La Tentation de la Force initialement prévue le 30 janvier est décalée au 13 février 2025.
#GalaxieSW+
www.galaxie-starwars.com/t12967-star-...
#StarWars
#GalaxieSW+
www.galaxie-starwars.com/t12967-star-...
#StarWars
January 20, 2025 at 4:03 PM
Oui, petit report de deux semaines. Les décalages, c'est toujours frustrant, mais celui-ci a néanmoins l'intérêt de nous rapprocher des publis comics et manga de la vague 2 ET de vous permettre de lire ce récit le jour de la Saint Valentin... Ce qui tombe plutôt pas mal 👉👈 #HauteRépublique #PhaseIII
The most consequential Phase III design decision isn't sample size or endpoints.
It's superiority vs non-inferiority — and the non-inferiority margin.
Get it wrong before enrollment begins and there is no recovery.
#PhaseIII #ClinicalTrials #DrugDevelopment #CRO
It's superiority vs non-inferiority — and the non-inferiority margin.
Get it wrong before enrollment begins and there is no recovery.
#PhaseIII #ClinicalTrials #DrugDevelopment #CRO
Phase III Clinical Trials: Designing the Pivotal Evidence That Wins Regulatory Approval
Learn in deatl about Phase III clinical Trials in India
genelifecr.blogspot.com
September 24, 2026 at 6:50 AM
The most consequential Phase III design decision isn't sample size or endpoints.
It's superiority vs non-inferiority — and the non-inferiority margin.
Get it wrong before enrollment begins and there is no recovery.
#PhaseIII #ClinicalTrials #DrugDevelopment #CRO
It's superiority vs non-inferiority — and the non-inferiority margin.
Get it wrong before enrollment begins and there is no recovery.
#PhaseIII #ClinicalTrials #DrugDevelopment #CRO
Just finished Defy The Storm! It was solid with some really intriguing developments! Venestra rocks.
Time for Temptation of the Force! I've seen it been called a masterpiece, so I'm really looking forward to diving in!
#StarWars #TheHighRepublic #PhaseIII
Time for Temptation of the Force! I've seen it been called a masterpiece, so I'm really looking forward to diving in!
#StarWars #TheHighRepublic #PhaseIII
January 21, 2026 at 1:40 AM
Just finished Defy The Storm! It was solid with some really intriguing developments! Venestra rocks.
Time for Temptation of the Force! I've seen it been called a masterpiece, so I'm really looking forward to diving in!
#StarWars #TheHighRepublic #PhaseIII
Time for Temptation of the Force! I've seen it been called a masterpiece, so I'm really looking forward to diving in!
#StarWars #TheHighRepublic #PhaseIII
We're building Australia's first centre for the designing and manufacturing personalised cancer vaccines at the BASE mRNA facility. On the PhaseIII podcast I discuss the transformative potential of mRNA for cancer and our efforts to bring this tech to patients.
podcasts.apple.com/au/podcast/v...
podcasts.apple.com/au/podcast/v...
VAXXED: Game on, with BASE and WEHI
Podcast Episode · Phase III · 19/11/2024 · 26m
podcasts.apple.com
November 19, 2024 at 11:25 PM
We're building Australia's first centre for the designing and manufacturing personalised cancer vaccines at the BASE mRNA facility. On the PhaseIII podcast I discuss the transformative potential of mRNA for cancer and our efforts to bring this tech to patients.
podcasts.apple.com/au/podcast/v...
podcasts.apple.com/au/podcast/v...
www.nature.com/articles/s41...
📖”Telitacicept, a dual inhibitor of BAFF and APRIL, has now been shown in a phase III randomized controlled trial to improve systemic lupus erythematosus (SLE) disease activity when added to standard therapy.”
#SLE #lupus #phaseIII
📖”Telitacicept, a dual inhibitor of BAFF and APRIL, has now been shown in a phase III randomized controlled trial to improve systemic lupus erythematosus (SLE) disease activity when added to standard therapy.”
#SLE #lupus #phaseIII
Phase III trial of telitacicept in SLE - Nature Reviews Rheumatology
In a phase III placebo-controlled trial, the addition of telitacicept to standard therapy led to increased clinical response rates for people with systemic lupus erythematosus.
www.nature.com
November 1, 2025 at 1:49 PM
www.nature.com/articles/s41...
📖”Telitacicept, a dual inhibitor of BAFF and APRIL, has now been shown in a phase III randomized controlled trial to improve systemic lupus erythematosus (SLE) disease activity when added to standard therapy.”
#SLE #lupus #phaseIII
📖”Telitacicept, a dual inhibitor of BAFF and APRIL, has now been shown in a phase III randomized controlled trial to improve systemic lupus erythematosus (SLE) disease activity when added to standard therapy.”
#SLE #lupus #phaseIII
Monthly Ivermectin Cuts Malaria Infection by 26% in Kenyan Phase III BOHEMIA Trial - buff.ly/Vr5dbuE #clinicaltrial #clinicaltrials #phaseiii #malaria
Monthly Ivermectin Cuts Malaria Infection by 26% in Kenyan Phase III BOHEMIA Trial
In the BOHEMIA study, once-monthly ivermectin over 3 months significantly reduced malaria incidence versus albendazole in children aged 5 to 15 years, supporting its role as a novel vector-control…
buff.ly
August 6, 2025 at 7:15 PM
Monthly Ivermectin Cuts Malaria Infection by 26% in Kenyan Phase III BOHEMIA Trial - buff.ly/Vr5dbuE #clinicaltrial #clinicaltrials #phaseiii #malaria
Dual-targeted therapies + chemo shows high response rates in BRAF-mutated metastatic CRC, phase III trial led by researchers at @mdanderson.bsky.social shows.
https://cancerletter.com/clinical-roundup/20250131_10a/
https://cancerletter.com/clinical-roundup/20250131_10a/
Dual-targeted therapies + chemo shows high response rates in BRAF-mutated metastatic CRC, phase III trial shows - The Cancer Letter
Patients with metastatic colorectal cancer harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies Braftovi(encorafenib) and Erbitux(cetuximab) plus a mFOLFOX6 chemotherapy regimen, according to results from the phaseIII BREAKWATER trial led by researchers at the University of Texas MD Anderson Cancer Center. To access this subscriber-only content please log in or subscribe.If […]
cancerletter.com
February 3, 2025 at 6:00 PM
Dual-targeted therapies + chemo shows high response rates in BRAF-mutated metastatic CRC, phase III trial led by researchers at @mdanderson.bsky.social shows.
https://cancerletter.com/clinical-roundup/20250131_10a/
https://cancerletter.com/clinical-roundup/20250131_10a/
🚀 Zacks Small Cap Research - ACHV: Looking Ahead to Resubmission
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-achv-looking-ahead-to-resubmission/
#ACHV #Ach#ACHVi#AchieveLifeSciencesc#Cytisiniclinee#SmokingCessation #NDA #FDAS#CRLs#NDASubmission #PhaseIIIS#ORCAhref="/hashtag/ATS20" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#ATS20
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-achv-looking-ahead-to-resubmission/
#ACHV #Ach#ACHVi#AchieveLifeSciencesc#Cytisiniclinee#SmokingCessation #NDA #FDAS#CRLs#NDASubmission #PhaseIIIS#ORCAhref="/hashtag/ATS20" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#ATS20
August 19, 2026 at 12:47 PM
🚀 Zacks Small Cap Research - ACHV: Looking Ahead to Resubmission
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-achv-looking-ahead-to-resubmission/
#ACHV #Ach#ACHVi#AchieveLifeSciencesc#Cytisiniclinee#SmokingCessation #NDA #FDAS#CRLs#NDASubmission #PhaseIIIS#ORCAhref="/hashtag/ATS20" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#ATS20
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-achv-looking-ahead-to-resubmission/
#ACHV #Ach#ACHVi#AchieveLifeSciencesc#Cytisiniclinee#SmokingCessation #NDA #FDAS#CRLs#NDASubmission #PhaseIIIS#ORCAhref="/hashtag/ATS20" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#ATS20
🚀 Zacks Small Cap Research - RADX: RAD101 Topline & FY:26 Cash Flows
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-radx-rad101-topline-fy26-cash-flows/
#RADX #Rad#RADXr#RadiopharmTheranosticsR#RAD101R#RAD202P#RAD204 #PhaseIII #PhaseIIb #MRIi#PETa#BrainMetastaseshref="/hashtag/Oncol" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Oncol
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-radx-rad101-topline-fy26-cash-flows/
#RADX #Rad#RADXr#RadiopharmTheranosticsR#RAD101R#RAD202P#RAD204 #PhaseIII #PhaseIIb #MRIi#PETa#BrainMetastaseshref="/hashtag/Oncol" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Oncol
August 4, 2026 at 7:04 AM
🚀 Zacks Small Cap Research - RADX: RAD101 Topline & FY:26 Cash Flows
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-radx-rad101-topline-fy26-cash-flows/
#RADX #Rad#RADXr#RadiopharmTheranosticsR#RAD101R#RAD202P#RAD204 #PhaseIII #PhaseIIb #MRIi#PETa#BrainMetastaseshref="/hashtag/Oncol" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Oncol
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-radx-rad101-topline-fy26-cash-flows/
#RADX #Rad#RADXr#RadiopharmTheranosticsR#RAD101R#RAD202P#RAD204 #PhaseIII #PhaseIIb #MRIi#PETa#BrainMetastaseshref="/hashtag/Oncol" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Oncol
Famotidine & loratadine (an "H1 blocker) together are under study in a PhaseIII trial of possible "Long Covid" (definitions vary) treatments.
Both have been used for decades, are over the counter (in US anyway) & cheap. My colleagues often recommend in post Covid.
pubmed.ncbi.nlm.nih.gov/36791116/
Both have been used for decades, are over the counter (in US anyway) & cheap. My colleagues often recommend in post Covid.
pubmed.ncbi.nlm.nih.gov/36791116/
December 20, 2023 at 9:55 PM
Famotidine & loratadine (an "H1 blocker) together are under study in a PhaseIII trial of possible "Long Covid" (definitions vary) treatments.
Both have been used for decades, are over the counter (in US anyway) & cheap. My colleagues often recommend in post Covid.
pubmed.ncbi.nlm.nih.gov/36791116/
Both have been used for decades, are over the counter (in US anyway) & cheap. My colleagues often recommend in post Covid.
pubmed.ncbi.nlm.nih.gov/36791116/
HUTCHMED Begins Phase III for HMPL-760: HUTCHMED initiated a Phase III trial for HMPL-760 in China on Mar 23, 2026, advancing its lymphoma program to a pivotal stage and shifting valuation drivers to execution and… 👈 Read full analysis #HUTCHMED #PhaseIII #HMPL760 #LymphomaTreatment #Oncology
HUTCHMED Begins Phase III for HMPL-760
HUTCHMED initiated a Phase III trial for HMPL-760 in China on Mar 23, 2026, advancing its lymphoma program to a pivotal stage and shifting valuation drivers to execution and differentiation.
dlvr.it
March 23, 2026 at 9:04 AM
HUTCHMED Begins Phase III for HMPL-760: HUTCHMED initiated a Phase III trial for HMPL-760 in China on Mar 23, 2026, advancing its lymphoma program to a pivotal stage and shifting valuation drivers to execution and… 👈 Read full analysis #HUTCHMED #PhaseIII #HMPL760 #LymphomaTreatment #Oncology
Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
$CRDL $CRDL.to #biotech #PhaseIII #clinicaltrials
//client
thedeepdive.ca/cardiol-sees...
$CRDL $CRDL.to #biotech #PhaseIII #clinicaltrials
//client
thedeepdive.ca/cardiol-sees...
Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolR…
thedeepdive.ca
April 17, 2025 at 12:02 PM
Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
$CRDL $CRDL.to #biotech #PhaseIII #clinicaltrials
//client
thedeepdive.ca/cardiol-sees...
$CRDL $CRDL.to #biotech #PhaseIII #clinicaltrials
//client
thedeepdive.ca/cardiol-sees...
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results - buff.ly/Fw0ftgq #clinicaltrial #clinicaltrials #phaseiii #fda #results
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results | Applied Clinical Trials Online
The FDA approval of oral semaglutide marks the first GLP-1 pill for chronic weight management, supported by Phase III OASIS 4 data demonstrating substantial weight loss, favorable safety, and…
buff.ly
December 24, 2025 at 8:15 PM
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results - buff.ly/Fw0ftgq #clinicaltrial #clinicaltrials #phaseiii #fda #results
Pfizer touts Tukysa in front-line breast cancer after Phase III victory - buff.ly/jrBxiAN #clinicaltrial #clinicaltrials #phaseiii #breastcancer
Pfizer touts Tukysa in front-line breast cancer after Phase III victory
Pfizer's Tukysa could become the first update to the maintenance regimen for HER2-positive breast cancer in over a decade if it were to be approved in this setting.
buff.ly
October 24, 2025 at 7:15 PM
Pfizer touts Tukysa in front-line breast cancer after Phase III victory - buff.ly/jrBxiAN #clinicaltrial #clinicaltrials #phaseiii #breastcancer
Kisunla Slows Cognitive and Functional Decline Over Three Years in Phase III Alzheimer Long-Term Extension Trial - buff.ly/sPTWyFN #clinicaltrial #clinicaltrials #alzheimer #longterm #phaseiii
Kisunla Slows Cognitive and Functional Decline Over Three Years in Phase III Alzheimer Long-Term Extension Trial
Results from the long-term extension of the Phase III TRAILBLAZER-ALZ 2 trial (NCT04437511) showed sustained benefits with early Kisunla treatment, including reduced risk of disease progression and…
buff.ly
August 8, 2025 at 7:15 PM
Kisunla Slows Cognitive and Functional Decline Over Three Years in Phase III Alzheimer Long-Term Extension Trial - buff.ly/sPTWyFN #clinicaltrial #clinicaltrials #alzheimer #longterm #phaseiii
MSD begins Phase III trial of dengue vaccine - buff.ly/XfWeiNS #clinicaltrial #clinicaltrials #denguevaccine #vaccine #phaseiii
MSD begins Phase III trial of dengue vaccine
MSD has begun the randomised MOBILIZE-1 Phase III trial to assess the investigational quadrivalent vaccine, V181.
buff.ly
June 16, 2025 at 7:15 PM
MSD begins Phase III trial of dengue vaccine - buff.ly/XfWeiNS #clinicaltrial #clinicaltrials #denguevaccine #vaccine #phaseiii
MSD’s Phase III trial of Keytruda meets endpoint for treating ovarian cancer - buff.ly/Rlzztcj #clinicaltrial #clinicaltrials #phaseiii #ovariancancer
MSD's Phase III trial of Keytruda meets endpoint for treating ovarian cancer
MSD has reported that the Phase III KEYNOTE-B96 trial of Keytruda plus paclitaxel, with or without bevacizumab, has met its primary goal.
buff.ly
May 16, 2025 at 7:15 PM
MSD’s Phase III trial of Keytruda meets endpoint for treating ovarian cancer - buff.ly/Rlzztcj #clinicaltrial #clinicaltrials #phaseiii #ovariancancer
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial - buff.ly/C603Pzw #clinicaltrial #clinicaltrials #phaseiii #pain #pharma
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial
Tris Pharma previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.
buff.ly
March 10, 2025 at 7:15 PM
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial - buff.ly/C603Pzw #clinicaltrial #clinicaltrials #phaseiii #pain #pharma
Was heisst 70% Wirksamkeit? Noch mehr als die von @EinguterMerlot erklärten statistischen Feinheiten zählt für mich: die Vakzine schützte in der PhaseIII zu 100% vor schweren Verläufen- NIEMAND musste mit #COVID19 ins Krankenhaus:...
February 2, 2025 at 12:45 AM
Was heisst 70% Wirksamkeit? Noch mehr als die von @EinguterMerlot erklärten statistischen Feinheiten zählt für mich: die Vakzine schützte in der PhaseIII zu 100% vor schweren Verläufen- NIEMAND musste mit #COVID19 ins Krankenhaus:...
18,735 lower courts computerised; Rs 7,210 cr sanctioned for eCourts Phase III yespunjab.com?p=72571
#eCourts #PhaseIII #JudicialReform #DigitalIndia #CourtModernization #LegalTech #IndianJustice #TechInLaw #JusticeForAll #FutureOfCourts #DigitalTransformation #CourtAutomation
#eCourts #PhaseIII #JudicialReform #DigitalIndia #CourtModernization #LegalTech #IndianJustice #TechInLaw #JusticeForAll #FutureOfCourts #DigitalTransformation #CourtAutomation
18,735 lower courts computerised; Rs 7,210 cr sanctioned for eCourts Phase III - Yes Punjab News
Over 18,000 district and subordinate courts in India have been computerised under the eCourts project, with new digital initiatives under Phase III aimed at enhancing access to justice through technol...
yespunjab.com
December 13, 2024 at 2:02 PM
18,735 lower courts computerised; Rs 7,210 cr sanctioned for eCourts Phase III yespunjab.com?p=72571
#eCourts #PhaseIII #JudicialReform #DigitalIndia #CourtModernization #LegalTech #IndianJustice #TechInLaw #JusticeForAll #FutureOfCourts #DigitalTransformation #CourtAutomation
#eCourts #PhaseIII #JudicialReform #DigitalIndia #CourtModernization #LegalTech #IndianJustice #TechInLaw #JusticeForAll #FutureOfCourts #DigitalTransformation #CourtAutomation